I-Mab Biopharma
IMAB
#9150
Rank
NZ$0.13 B
Marketcap
$1.63
Share price
-3.17%
Change (1 day)
-33.70%
Change (1 year)

I-Mab Biopharma (IMAB) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$26.17 Million

According to I-Mab Biopharma's latest financial reports the company's total liabilities are NZ$26.17 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

I-Mab Biopharma - Total liabilities on balance sheet (from 2024 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$0.26 B11.05%
2021-12-31NZ$0.23 B59.38%
2020-12-31NZ$0.15 B-81.27%
2019-12-31NZ$0.80 B11.04%
2018-12-31NZ$0.72 B151.77%
2017-12-31NZ$0.28 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$21.5 M-17.85%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.50 B 5,661.78%๐Ÿ‡บ๐Ÿ‡ธ USA